Fortrea Holdings (FTRE) Non-Current Debt (2023 - 2026)
Fortrea Holdings' (FTRE) quarterly Non-Current Debt came in at $1.0 billion in Q2 2026, down 5.79% on a YoY basis from $1.1 billion in Q2 2025, and down 0.52% quarter-over-quarter from $1.0 billion in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Non-Current Debt (2023 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Non-Current Debt for 4 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Debt fell 5.79% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $1.0 billion (down 5.79% YoY), and the FY2025 full-year result was $1.0 billion, changed 0.16% from the prior year.
- Non-Current Debt slipped to $1.0 billion in Q2 2026 per FTRE's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.6 billion in Q2 2023 and bottomed at $1.0 billion in Q2 2026.
- Historically, Non-Current Debt has averaged $1.2 billion across 4 years, with a median of $1.1 billion in 2025.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt tumbled 32.97% in 2024, then fell 0.16% in 2025.
- Over 4 years, Non-Current Debt stood at $1.6 billion in 2023, then plunged by 32.97% to $1.0 billion in 2024, then fell by 0.16% to $1.0 billion in 2025, then dropped by 1.03% to $1.0 billion in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $1.0 billion, $1.0 billion, and $1.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 13.71 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 2.62 Bn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 2.11 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 1.04 Bn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 481.59 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.12 Bn |
| Mar 31, 2024 | 1.56 Bn |
| Dec 31, 2023 | 1.57 Bn |
| Sep 30, 2023 | 1.57 Bn |
| Jun 30, 2023 | 1.58 Bn |